Merck Unit Hit With €15.3M Competition Fine In France
France's competition authority slammed Merck & Co.'s Schering-Plough unit with a €15.3 million fine ($20.9 million) Thursday for allegedly attempting to curb generic competition for its opioid dependence drug Subutex....To view the full article, register now.
Already a subscriber? Click here to view full article